Neoadjuvant lorlatinib in resectable stage IB-IIIB ALK-rearranged NSCLC: Simon stage 1 analysis of NEOLORA study (ESMO Asia 2026) - Oct 1, 2026 - Abstract #911P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Clinical • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • ALK
|
|
Fan Yang; Xiang Yan; Heng Zhao; Xiaolong Yan; Yong Liu; Hongxu Liu; Desong Yang; Junqiang Fan; Yang Xia; Zheng Liang Tu; Lixin Zhou; Geyun Chang
|